Treatment-related biomarkers in pulmonary hypertension patients on oral therapies

Treatment-related biomarkers in pulmonary hypertension patients on oral therapies

Abstract Background Multiple classes of oral therapy are available for the treatment of pulmonary arterial hypertension (PAH), but there is little to guide clinicians in choosing a specific regimen or therapeutic class. We aimed to investigate whether treatment-relevant blood biomarkers can predict...

Full description

Bibliographic Details
Main Authors: Aparna C. Swaminathan, Hongmei Zhu, Victor Tapson, Yuliya Lokhnygina, Abby Poms, Zach Kelleher, Elijah Gaspard, Karla Kennedy, Brian E. Fee, Terry Fortin, S. Nicholas Mason, Kishan Parikh, Tim J. McMahon
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Respiratory Research
Subjects:
Pulmonary hypertension
Biomarkers
Nitric oxide
Endothelin-1
Online Access:http://link.springer.com/article/10.1186/s12931-020-01566-y

Internet

http://link.springer.com/article/10.1186/s12931-020-01566-y

Similar Items